Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-09-10 Sale | 2026-09-14 4:00 pm | Amylyx Pharmaceuticals Inc. | AMLX | Bedrosian Camille L Chief Medical Officer | 10,028 | $32.4 | $324,868 | 278,064 (Direct) | View |
| 2026-09-10 Sale | 2026-09-14 4:00 pm | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 10,810 | $32.36 | $349,821 | 400,156 (Indirect Direct) | View |
| 2026-09-10 Sale | 2026-09-14 4:00 pm | Amylyx Pharmaceuticals Inc. | AMLX | Mazzariello Gina Chief Legal Officer | 9,536 | $32.46 | $309,506 | 190,838 (Direct) | View |
| 2026-09-10 Sale | 2026-09-14 4:00 pm | Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer | 30,464 | $32.18 | $980,263 | 3,613,056 (Direct) | View |
| 2026-09-10 Sale | 2026-09-14 4:00 pm | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 30,464 | $32.19 | $980,504 | 3,613,123 (Direct) | View |
| 2026-07-09 Sale | 2026-07-13 4:00 pm | Amylyx Pharmaceuticals Inc. | AMLX | Mazzariello Gina Chief Legal Officer | 30,000 | $17.96 | $538,868 | 179,090 (Direct) | View |
| 2026-05-21 Purchase | 2026-05-26 4:00 pm | Amylyx Pharmaceuticals Inc. | AMLX | Firestone Karen Director | 3,800 | $13.51 | $51,338 | 66,900 (Direct) | View |
| 2026-03-02 Sale | 2026-03-04 4:00 pm | Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer | 29,282 | $14.47 | $423,760 | 3,334,616 (Direct) | View |
| 2026-03-02 Sale | 2026-03-04 4:00 pm | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 29,282 | $14.48 | $424,120 | 3,334,683 (Direct) | View |
| 2026-03-02 Sale | 2026-03-04 4:00 pm | Amylyx Pharmaceuticals Inc. | AMLX | Bedrosian Camille L Chief Medical Officer | 6,461 | $14.58 | $94,205 | 169,295 (Direct) | View |
| 2026-03-02 Sale | 2026-03-04 4:00 pm | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 7,909 | $14.52 | $114,851 | 292,169 (Indirect Direct) | View |
| 2026-03-02 Sale | 2026-03-04 4:00 pm | Amylyx Pharmaceuticals Inc. | AMLX | Mazzariello Gina Chief Legal Officer | 6,844 | $14.52 | $99,378 | 134,430 (Direct) | View |
| 2026-02-23 Sale | 2026-02-25 4:00 pm | Amylyx Pharmaceuticals Inc. | AMLX | Mazzariello Gina Chief Legal Officer | 3,419 | $14.14 | $48,352 | 141,274 (Direct) | View |
| 2026-02-02 Sale | 2026-02-04 4:05 pm | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 3,557 | $14.65 | $52,097 | 300,078 (Indirect Direct) | View |
| 2026-02-02 Sale | 2026-02-04 4:05 pm | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 15,500 | $14.68 | $227,593 | 3,363,965 (Direct) | View |
| 2026-02-02 Sale | 2026-02-04 4:05 pm | Amylyx Pharmaceuticals Inc. | AMLX | Mazzariello Gina Chief Legal Officer | 3,448 | $14.65 | $50,516 | 144,693 (Direct) | View |
| 2026-02-02 Sale | 2026-02-04 4:05 pm | Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer | 15,500 | $14.69 | $227,618 | 3,363,898 (Direct) | View |
| 2026-01-15 Sale | 2026-01-20 9:46 pm | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 138,167 | $13.59 | $1,878,094 | 3,382,283 (Direct) | View |
| 2026-01-15 Sale | 2026-01-20 9:46 pm | Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer | 138,188 | $13.59 | $1,877,570 | 3,382,245 (Direct) | View |
| 2026-01-06 Sale | 2026-01-08 4:05 pm | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 3,326 | $11.11 | $36,954 | 303,635 (Indirect Direct) | View |
| 2026-01-06 Sale | 2026-01-08 4:05 pm | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 7,715 | $11.09 | $85,596 | 3,317,632 (Direct) | View |
| 2026-01-06 Sale | 2026-01-08 4:05 pm | Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer | 7,715 | $11.09 | $85,589 | 3,317,586 (Direct) | View |
| 2025-12-23 Purchase | 2025-12-23 8:48 pm | Amylyx Pharmaceuticals Inc. | AMLX | Firestone Karen Director | 8,100 | $12.45 | $100,845 | 63,100 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-31 Exercise | 2026-09-02 4:00 pm | N/A 2034-06-05 | Amylyx Pharmaceuticals Inc. | AMLX | Firestone Karen Director | 50,000 | $0 | 116,900 (Direct) | View |
| 2026-08-31 Exercise | 2026-09-02 4:00 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Firestone Karen Director | 25,000 | $1.76 | 116,900 (Direct) | View |
| 2026-08-31 Exercise | 2026-09-02 4:00 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Firestone Karen Director | 25,000 | $5.05 | 116,900 (Direct) | View |
| 2026-08-18 Option Award | 2026-08-20 9:00 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 22,807 | $0 | 410,966 (Direct) | View |
| 2026-08-18 Option Award | 2026-08-20 9:00 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer | 60,039 | $0 | 3,643,520 (Direct) | View |
| 2026-08-18 Option Award | 2026-08-20 9:00 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Mazzariello Gina Chief Legal Officer | 21,284 | $0 | 200,374 (Direct) | View |
| 2026-08-18 Option Award | 2026-08-20 9:00 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Bedrosian Camille L Chief Medical Officer | 22,807 | $0 | 288,092 (Direct) | View |
| 2026-08-18 Option Award | 2026-08-20 9:00 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 60,039 | $0 | 3,643,587 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-08 4:00 pm | N/A 2036-06-03 | Amylyx Pharmaceuticals Inc. | AMLX | Zeiher Bernhardt G Director | 24,372 | $0 | 24,372 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-08 4:00 pm | N/A 2036-06-03 | Amylyx Pharmaceuticals Inc. | AMLX | Firestone Karen Director | 24,372 | $0 | 24,372 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-08 4:00 pm | N/A 2036-06-03 | Amylyx Pharmaceuticals Inc. | AMLX | Quimi Daphne Director | 24,372 | $0 | 24,372 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-08 4:00 pm | N/A 2036-06-03 | Amylyx Pharmaceuticals Inc. | AMLX | MILNE GEORGE M JR Director | 24,372 | $0 | 24,372 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-08 4:00 pm | N/A 2036-06-03 | Amylyx Pharmaceuticals Inc. | AMLX | FONTEYNE PAUL R. Director | 24,372 | $0 | 24,372 (Direct) | View |
| 2026-03-05 Option Award | 2026-03-09 4:00 pm | N/A 2036-03-05 | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 622,160 | $0 | 3,956,843 (Direct) | View |
| 2026-03-05 Option Award | 2026-03-09 4:00 pm | N/A 2036-03-05 | Amylyx Pharmaceuticals Inc. | AMLX | Mazzariello Gina Chief Legal Officer | 186,650 | $0 | 321,080 (Direct) | View |
| 2026-03-05 Option Award | 2026-03-09 4:00 pm | N/A 2036-03-05 | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 239,975 | $0 | 532,144 (Direct) | View |
| 2026-03-05 Option Award | 2026-03-09 4:00 pm | N/A 2036-03-05 | Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer | 622,160 | $0 | 3,956,776 (Direct) | View |
| 2026-03-05 Option Award | 2026-03-09 4:00 pm | N/A 2036-03-05 | Amylyx Pharmaceuticals Inc. | AMLX | Bedrosian Camille L Chief Medical Officer | 239,975 | $0 | 409,270 (Direct) | View |
| 2026-01-15 Exercise | 2026-01-20 9:46 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 200,000 | $7.57 | 3,382,283 (Direct) | View |
| 2026-01-15 Exercise | 2026-01-20 9:46 pm | N/A 2026-02-19 | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 200,000 | $0 | 3,382,283 (Direct) | View |
| 2026-01-15 Exercise | 2026-01-20 9:46 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer | 200,000 | $7.57 | 3,382,245 (Direct) | View |
| 2026-01-15 Exercise | 2026-01-20 9:46 pm | N/A 2026-02-19 | Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer | 200,000 | $0 | 3,382,245 (Direct) | View |
| 2026-01-12 Gift | 2026-01-14 4:08 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | MILNE GEORGE M JR Director | 17,780 | $0 | 812,881 (Direct) | View |